XML 52 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
6 Months Ended 12 Months Ended
Aug. 30, 2014
Aug. 31, 2013
Mar. 01, 2014
Mar. 02, 2013
Operating activities:        
Net income $ 36,814 $ 30,707    
Adjustments to reconcile net income to net cash provided by operating activities:        
Impairment charges 2,332 0    
Depreciation and amortization 19,401 17,949    
Deferred income taxes 2,302 267    
Loss on disposals of property and equipment 643 522    
Gain on settlement of contingent consideration (1,103) 0    
Share-based compensation 4,244 3,382    
Excess tax benefits from share-based compensation (1,646) (2,108)    
Changes in operating assets and liabilities:        
Accounts receivable, net 1,082 455    
Merchandise inventories, net (24,360) (48,899)    
Other assets 6,483 (3,836)    
Accounts payable 5,368 33,011    
Employee compensation (9,920) 2,671    
Income taxes payable (4,888) 3,517    
Other liabilities and accrued expenses (196) 2,026    
Deferred credits from landlords 2,198 949    
Net cash provided by operating activities 38,754 40,613    
Investing activities:        
Capital expenditures for property and equipment (43,949) (43,206)    
Acquisitions, net of cash acquired (4,674) (8,315)    
Proceeds from disposals of property and equipment 16 52    
Cash paid for investment (750) 0    
Net cash used in investing activities (49,357) (51,469)    
Financing activities:        
Dividends paid to shareholders (7,763) (6,756)    
Proceeds from issuance of common stock 5,727 4,610    
Excess tax benefits from share-based compensation 1,646 2,108    
Purchase of treasury stock (22,243) (12,256)    
Purchase of redeemable noncontrolling interest (9,000) 0    
Proceeds from repayment of related-party promissory note 4,090 0    
Cash paid for settlement of contingent consideration (350) 0    
Net cash used in financing activities (27,893) (12,294)    
Net decrease in cash and cash equivalents (38,496) (23,150)    
Cash and cash equivalents at beginning of period 229,079 226,982 226,982  
Cash and cash equivalents at end of period 190,583 203,832 229,079 226,982
Supplemental disclosure of noncash operating and investing activities:        
Capital expenditures incurred but not yet paid $ 9,996 $ 6,639 $ 9,200 $ 9,715